NeoGenomics (NEO): A Genomic Stock Worth Checking?
NeoGenomics Inc. (NASDAQ:NEO), founded in 2002, runs a laboratory network across the U.S., with a prime focus on cancer genetics diagnostic testing. It...
Posts Tagged ‘NASDAQ:NEO’
Is NEO A Good Stock To Buy Now?
In this article we are going to use hedge fund sentiment as a tool and determine whether NeoGenomics, Inc. (NASDAQ:NEO) is a good investment right now...
Top 10 Healthcare Stocks To Buy for the Future
In this article we present the list of Top 10 Healthcare Stocks To Buy for the Future. Click to skip ahead and see the Top 5 Healthcare Stocks for the...
Hedge Funds Are Piling Into NeoGenomics, Inc. (NEO)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Hedge Funds Are Souring On NeoGenomics, Inc. (NEO)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Hedge Funds Were Dumping NeoGenomics, Inc. (NEO) Before The Coronavirus
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
Did Hedge Funds Drop The Ball On NeoGenomics, Inc. (NEO) ?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook...
Hedge Fund and Insider Trading News: Paul Tudor Jones, Bodenholm Capital, Kingstown Capital Management, Mettler-Toledo International Inc. (MTD), AvalonBay Communities Inc (AVB), and More
Hedge-Fund Legend Paul Tudor Jones: ‘I‘m Very Bullish on US Stocks‘ (StockDailyDish.com) Hedge-fund manager said Monday he is bullish U.S. stocks...
Is NeoGenomics, Inc. (NEO) Going To Burn These Hedge Funds ?
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms...
Did Hedge Funds Drop The Ball On NeoGenomics, Inc. (NEO) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on...
Hedge Funds Have Never Been This Bullish On NeoGenomics, Inc. (NEO)
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors...
NeoGenomics, Inc. (NEO): Hedge Funds Are Snapping Up
During the first half of the fourth quarter the Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by about 4 percentage points as investors...
Hedge Fund and Insider Trading News: Steve Cohen, Crispin Odey, Jana Partners, Verrica Pharmaceuticals Inc (VRCA), Easterly Acquisition Corp (EACQ), Progressive Corp (PGR), and More
Steve Cohen Says Returns Won’t Be Very Good Over the Next Two Years, Bear Market Possible (CNBC) Billionaire Steve Cohen sees the U.S. economy slowing...
Is NeoGenomics, Inc. (NEO) A Good Stock To Buy?
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil...
Do Hedge Funds Love NeoGenomics, Inc. (NEO)?
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by...
What Sparked the Large Moves of These Five Stocks?
It’s Wednesday, and shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Concordia Healthcare Corp (NASDAQ:CXRX), SanDisk Corporation (NASDAQ:...
Carl Wiese’s Grow Partners Top Picks in Q4
Carl Wiese founded Grow Partners in 2012. Wiese has more than 22 years of investment management experience. Prior to launching Grow Partners, he worked...
Trius Therapeutics, Inc. (TSRX): Are Hedge Funds Right About This Stock?
Trius Therapeutics, Inc. (NASDAQ:TSRX) was in 8 hedge funds’ portfolio at the end of December. TSRX has experienced a decrease in enthusiasm from...
